Evidence map›Paper›PMID 41393211›Full record

ArticleRSC advances2025

Rational design of highly dispersed ultra-small Ru nanoparticles on MgO-Al

Yongjun Wang, Cheng Han, Xiaohan Wu, Minglin Xiang, Tao Liu, Xiaoshan Zhang, Bing Wang, Yingde Wang

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yongjun WangScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.
Cheng HanScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.ORCID https://orcid.org/0000-0003-1919-7483
Xiaohan WuScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.
Minglin XiangHunan Changlian Newmaterial Technology CO., Ltd Yueyang 414012 P.R.China.
Tao LiuScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.
Xiaoshan ZhangScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.
Bing WangScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.
Yingde WangScience and Technology on Advanced Ceramic Fibers and Composites Laboratory, College of Aerospace Science and Engineering, National University of Defense Technology Changsha 410073 P.R.China wangyingde@nudt.edu.cn hancheng@nudt.edu.cn.ORCID https://orcid.org/0000-0001-8615-194X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous selective hydrogenation of aromatic compounds exhibits broad application prospects, serving as a key process for the synthesis of high-value-added polymer monomers and pharmaceutical intermediates. The fabrication of heterogeneous catalysts being even more critical to enabling this continuous process. Herein, the traditional preparation protocol of supported Ru-based catalysts was systematically optimized, resulting in a novel Ru/MgO-Al

Identifiers

PMID41393211
PMCPMC12700224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.